DHG Pharmaceutical JSCSTC:DHG 78 Days Payable is 56.26 as of Mar. 2026, which is 47% above its 10-year median of 38.35. GuruFocus rates STC:DHG with a GF Score™ of 78/100 and a GF Value™ of ₫113,390.11 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 920 Drug Manufacturers companies, DHG Pharmaceutical JSC ranks worse than 81.3% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DHG Pharmaceutical JSC Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's Days Payable distribution charts can be found below:
* The bar in red indicates where DHG Pharmaceutical JSC's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
DHG Pharmaceutical JSC's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHG Pharmaceutical JSC (STC:DHG) has a Days Payable of 56.26 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DHG Pharmaceutical JSC and its competitors. This is 47% above median its historical median of 38.35. Over the past decade, DHG Pharmaceutical JSC's Days Payable has ranged from 22.23 to 45.55. According to the industry distribution chart, DHG Pharmaceutical JSC ranks #748 out of 920 companies in the Drug Manufacturers industry, placing it in the top 81.3%.
Is DHG Pharmaceutical JSC's Days Payable too high?
DHG Pharmaceutical JSC's current Days Payable of 56.26 is 47% above median its 10-year median of 38.35. Over the past 10 years, this metric has ranged from a low of 22.23 to a high of 45.55. The Drug Manufacturers industry median Days Payable is 90.84. DHG Pharmaceutical JSC's value of 56.26 is 38.1% below this industry median. Based on the distribution chart, DHG Pharmaceutical JSC ranks #748 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, DHG Pharmaceutical JSC has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, DHG Pharmaceutical JSC ranks #748 out of 920 companies for Days Payable. This places DHG Pharmaceutical JSC in the lower half of its industry. The industry median Days Payable is 90.84. DHG Pharmaceutical JSC's value of 56.26 is 38.1% below this benchmark. Historically, DHG Pharmaceutical JSC's own Days Payable has ranged from 22.23 to 45.55 over the past decade. While the company's 10-year median is 38.35 vs. the industry median of 90.84, DHG Pharmaceutical JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DHG Pharmaceutical JSC's current Days Payable of 56.26 is 38.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DHG Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DHG Pharmaceutical JSC's current Days Payable is 56.26, which is 47% above median its own 10-year median of 38.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,390.11, compared to a current price of ₫93,800.00 — trading 17.3% below its estimated fair value. The current Days Payable is 56.26, which is 47% above median its 10-year median of 38.35 and 38.1% below the Drug Manufacturers industry median of 90.84. DHG Pharmaceutical JSC's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current Days Payable is 56.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued.
The current stock price of ₫93,800.00 is trading 17.3% below its estimated GF Value™ of ₫113,390.11.
GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.
Key valuation signals for STC:DHG:
Days Payable: 56.26 (47% above median its 10-year median of 38.35)
GF Value™: ₫113,390.11 vs. price of ₫93,800.00 (17.3% below fair value)
Industry Position: 38.1% below the Drug Manufacturers median (#748 of 920)
No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
78GF Score
Get the complete analysis for STC:DHG
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DHG has been successfully added to your 
